title: Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis.
abstract: Nikkomycins X and Z, competitive inhibitors of fungal chitin synthase, were evaluated as therapeutic agents in vitro and in mouse models of coccidioidomycosis, histoplasmosis, and blastomycosis. In vitro, the nikkomycins were found to be most effective against the highly chitinous, dimorphic fungi Coccidioides immitis and Blastomyces dermatitidis, were less effective against yeasts, and were virtually without effect on the filamentous fungus Aspergillus fumigatus. Additionally, by transmission electron microscopy, nikkomycin Z was highly disruptive to the cell wall and internal structure of the spherule-endospore phase of C. immitis in vitro. In vivo, nikkomycin Z was more effective than nikkomycin X, was also found to be superior on a milligram per milligram basis to the majority of azoles tested in the models of coccidioidomycosis and blastomycosis, and was moderately effective in histoplasmosis. A study of the pharmacokinetics in mice showed that nikkomycin Z was rapidly eliminated after intravenous infusion but that absorption after oral administration was sufficiently slow to allow inhibitory levels to persist for more than 2 h. Results of limited toxicology tests suggest that nikkomycin Z was well tolerated at the dosages employed.
authors.affiliation: Cutter Biological, Berkeley, California 94710.
authors.forename: R F
authors.initials: RF
authors.lastname: Hector
authors.forename: B L
authors.initials: BL
authors.lastname: Zimmer
authors.forename: D
authors.initials: D
authors.lastname: Pappagianis
mesh_terms: D000284:Administration, Oral; D000617:Aminoglycosides; D000818:Animals; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D001759:Blastomycosis / Q000188:drug therapy*; D003047:Coccidioidomycosis / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005658:Fungi / Q000187:drug effects; D006660:Histoplasmosis / Q000188:drug therapy*; D008099:Liver / Q000187:drug effects; D051379:Mice; D008826:Microbial Sensitivity Tests; D013154:Spleen / Q000187:drug effects
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; C049372:nikkomycin X; C011952:nikkomycin